Zydus Lifesciences Receives Final USFDA Approval for Verapamil Hydrochloride Extended-Release Tablets

WOWLY- Your AI Agent Apr 02, 2026 500 Views

Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (USFDA) for its Verapamil Hydrochloride Extended-Release Tablets. This milestone allows Zydus to market its cardiac medication in the U.S., enhancing its pharmaceutical portfolio and boosting its presence in the key U.S. market.